Transforming Maternal Health (TMaH) Model

 

The Transforming Maternal Health (TMaH) Model, is a voluntary, 10-year delivery and payment model promoting improved maternal health care outcomes. The TMaH model will test whether funded targeted technical assistance, coupled with payment and delivery system reforms, can drive a whole-person care-delivery approach to pregnancy, childbirth, and postpartum care while reducing Medicaid and CHIP program expenditures. CMS will evaluate: TMaHs impact on rates of low-risk cesarean section (c-section), severe maternal morbidity (SMM), incidence of low birthweight infants, changes in experience of care for pregnant and birthing people, and changes in program expenditures.

Active 93.869 Centers For Medicare and Medicaid Services, Department of Health and Human Services B - Project Grants Not applicable. Section 1115A of the Social Security Act (the Act) establishes CMMI to test innovative health care payment and service delivery models that have the potential to lower Medicare, Medicaid, and CHIP spending while maintaining or improving the quality of beneficiaries’ care., Title Social Security Act, Section 1115A State Requirements - An applicant to this NOFO must propose to implement the Model in a substate region specified by ZIP codes, in which the average number of annual births between 2015-2020 was no fewer than 1000. Pregnant or postpartum (up to 12 months) people who are Medicaid beneficiaries within the service areas. Pregnant or postpartum (up to 12 months) people who are CHIP beneficiaries within the service areas will be eligible in some states. Not applicable. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Interested applicants will submit their applications via grants.gov. All qualified applications will be forwarded to a merit review committee. The results of the merit review of the applications by qualified experts will be used to advise the CMS approving official. In making these decisions, the CMS approving official will take into consideration: recommendations of the review panel; the readiness of the applicant to conduct the work required; the scope of overall projected impact on the aims; reviews for programmatic and grants management compliance; the reasonableness of the estimated cost to the government and anticipated results; and the likelihood that the proposed project will result in the benefits expected. Notification is made in writing by a Notice of Award (NoA). 11:59pm EST August 30, 2024 (Baltimore, MD) Application review period will take approximately 60 business days Not applicable. Not applicable. To be determined Cooperative Agreement funding will support the following activities: • Grow midwifery workforce and expand birth center access • Provide doula service benefits • Improve Data Infrastructure and Interoperability • Design a Payment Model • Support Hospitals to attain Birthing Friendly Hospital Designation • Implement AIM patient safety bundles • Risk assess and screen, refer and follow-up for perinatal depression, anxiety, tobacco use, substance use disorder, and HRSN • Home monitoring for hypertension and diabetes • Health Equity Planning • Increase Access to remote patient monitoring. • Expand group perinatal care • Promote Shared Decision-Making • Extend Medicaid Coverage to 12 months postpartum Not applicable. Not applicable. Recipients are required to maintain grant accounting records 3 years after the date they submit the final Federal Financial Report. If any litigation, claim, negotiation, audit or other action involving the award has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. The estimated period of performance is 10 years. Funding for each year after Model Year 1 will be issued via non-competing continuation awards, contingent on SMA progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award. Method of awarding/releasing assistance: Quarterly. None/Not specified. Adam Conway
7500 Security Blvd.
Windsor Mill, MD 21244 USA
Adam.Conway1@cms.hhs.com
Phone: 443 621 0783

Linda Streitfeld
7500 Security Blvd.
Windsor Mill, MD 21244 USA
Linda.Streitfeld1@cms.hhs.gov
Phone: 410 786 8970 75-0522-0-1-551 (Cooperative Agreements) FY 23$0.00; FY 24 est $0.00; FY 25 est $15,000,000.00; FY 22$0.00; - CMS will make a total of $17 million each available to State Medicaid Agencies. Awardees will engage in a three year Pre-Implementation period in which they will receive structured TA to meet the model aims. Awardees will receive up to $8 million for the Pre-Implementation Period and up to $9 million during the following seven years of implementation. CMS will make a total of $17 million each available to State Medicaid Agencies. Awardees will engage in a three year Pre-Implementation period in which they will receive structured TA to meet the model aims. Awardees will receive up to $4 million for the Pre-Implementation Period and up to $13million during the following seven years of implementation. Not applicable. Not applicable.